SCHEMBL17632104

SCHEMBL17632104

N#CN(C(=O)[C@H]1CCNC1)c1ncc(C2CCOCC2)s1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ CDK9 P50750 2/20 0.31
▸ JAK2 O60674 1/20 0.30
▸ JAK3 P52333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17631911 0.82 UCHL1 (0.45) CDK9JAK2JAK3
SCHEMBL17631689 0.81 SMN1; SMN2 (0.35) CDK9
SCHEMBL17631706 0.81 GAA (0.36) —
SCHEMBL17632005 0.79 — —
SCHEMBL17632085 0.78 CDK9 (0.36) CDK9
SCHEMBL17632036 0.77 USP30 (0.50) —
SCHEMBL17631923 0.76 UCHL1 (0.50) —
SCHEMBL17632487 0.76 USP30 (0.41) —
SCHEMBL17632491 0.76 CHEK1 (0.42) SLC6A2SLC6A4
SCHEMBL17631612 0.76 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback